1. Home
  2. GLBS vs XLO Comparison

GLBS vs XLO Comparison

Compare GLBS & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globus Maritime Limited

GLBS

Globus Maritime Limited

HOLD

Current Price

$3.07

Market Cap

65.4M

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$8.10

Market Cap

56.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLBS
XLO
Founded
2006
2016
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
65.4M
56.9M
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
GLBS
XLO
Price
$3.07
$8.10
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 129.7K
10.3K
Earning Date
11-27-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $43,766,000.00
Revenue This Year
$39.12
N/A
Revenue Next Year
$2.76
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 589.88
52 Week Low
$1.04
$0.46
52 Week High
$4.06
$25.17

Technical Indicators

Market Signals
Indicator
GLBS
XLO
Relative Strength Index (RSI) 38.57 31.61
Support Level $2.71 $7.37
Resistance Level $3.19 $8.97
Average True Range (ATR) 0.21 0.43
MACD -0.03 -0.09
Stochastic Oscillator 24.24 6.71

Price Performance

Historical Comparison
GLBS
XLO

About GLBS Globus Maritime Limited

Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

Share on Social Networks: